# Michael F. Berger

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-f-berger/

## Facts

| Field | Value |
| --- | --- |
| Citations | 92,236 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 133 |
| i10-index | 355 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5037092952 |
| ORCID iD | 0000-0003-3882-5000 |
| Works | 1,357 |

## Researcher papers

Showing 12 of 27.

- [The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity](https://scholariq.org/papers/the-cancer-cell-line-encyclopedia-enables-predictive-modelling-of-anticancer/)
- [Tumor mutational load predicts survival after immunotherapy across multiple cancer types](https://scholariq.org/papers/tumor-mutational-load-predicts-survival-after-immunotherapy-across-multiple/)
- [OncoKB: A Precision Oncology Knowledge Base](https://scholariq.org/papers/oncokb-a-precision-oncology-knowledge-base/)
- [The Mutational Landscape of Head and Neck Squamous Cell Carcinoma](https://scholariq.org/papers/the-mutational-landscape-of-head-and-neck-squamous-cell-carcinoma/)
- [Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing](https://scholariq.org/papers/development-and-validation-of-a-clinical-cancer-genomic-profiling-test-based-on/)
- [Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)](https://scholariq.org/papers/memorial-sloan-kettering-integrated-mutation-profiling-of-actionable-cancer/)
- [AACR Project GENIE: Powering Precision Medicine through an International Consortium](https://scholariq.org/papers/aacr-project-genie-powering-precision-medicine-through-an-international/)
- [Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer](https://scholariq.org/papers/inherited-dna-repair-gene-mutations-in-men-with-metastatic-prostate-cancer/)
- [Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing](https://scholariq.org/papers/molecular-determinants-of-response-to-anti-programmed-cell-death-pd-1-and-anti/)
- [Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers](https://scholariq.org/papers/extracellular-vesicle-and-particle-biomarkers-define-multiple-human-cancers/)
- [Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy](https://scholariq.org/papers/patient-hla-class-i-genotype-influences-cancer-response-to-checkpoint-blockade/)
- [The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers](https://scholariq.org/papers/the-genomic-landscape-of-endocrine-resistant-advanced-breast-cancers/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.